Evidence-based recommendations are presented for the management of hidradenitis suppurativa (HS) in guidelines of care issued by the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation and published online Oct. 20 in the Journal of the American Academy of Dermatology.
Evidence-Based Guidelines for Managing Hidradenitis Suppurativa Released
The American Academy of Dermatology and the Hidradenitis Suppurativa Foundation have released evidence-based guidelines for managing hidradenitis suppurativa, published on October 20. This development is significant for healthcare practices in Iran, where dermatological conditions may require updated treatment protocols. The guidelines aim to improve patient care and outcomes.
👥 Key Players
📰 What Happened
The American Academy of Dermatology and the Hidradenitis Suppurativa Foundation released new guidelines for managing hidradenitis suppurativa, aimed at improving patient care.
- The guidelines are evidence-based and published in a reputable medical journal.
- They are intended to standardize treatment approaches for HS.
💡 Why It Matters
📚 Background
Hidradenitis suppurativa is a chronic skin condition that can severely impact quality of life, making effective management essential.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%